Released Mar 18, 2013, before the open
10-K filed Mar 18, 2013, 77 days after period end · 0001144204-13-015576
Q4 2012 · 10-K
Revenue—
Net Income-$3.79M-$3.79M N/M vs Q4 2011N/M vs Q3 2012
EPS Diluted-$0.29-$0.29 N/M vs Q4 2011N/M vs Q3 2012
Operating Incomederived-$3,816,830N/M
What the release said
No earnings release is on file for this quarter. Its figures came with the 10-K.
Same quarter
| Metric | Q4 2012 | Q4 2011 | Q4 2010dderived from reported figures |
|---|---|---|---|
| Net Income | -$3.79M | -$18.86M | — |
| EPS Diluted | -$0.29 | -$1.52 | — |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Assembly Biosciences, Inc. · CIK 1426800 · Engraved from SEC EDGAR